Ascorbyl Glucoside is primarily used for its role in protecting the skin against oxidative stress. It thus helps the skin combat free radicals, unstable molecules that, by reacting with cellular components, can degrade them. Free radicals can notably impair the network of collagen and elastin of the extracellular matrix and accelerate skin laxity and the appearance of wrinkles. Regular use of antioxidants, such as ascorbyl glucoside, helps prevent this process.
A comparative study conducted on human skin explants evaluated cutaneous delivery, stability, and antioxidant efficacy of a formula containing 1.8% ascorbyl glucoside compared to another containing 15% ascorbic acid. The results show that ascorbyl glucoside is fully converted into ascorbic acid by the skin before crossing the skin barrier, while leaving an unmetabolized fraction in the tissues, thus forming a reservoir available for subsequent conversion. This kinetic profile suggests a sustained antioxidant action over time, rather than a transient activity peak.
Functionally, antioxidant efficacy was assessed using several oxidative stress markers, including malondialdehyde (MDA), superoxide dismutase (SOD), and catalase. Despite a higher absolute amount of ascorbic acid in the skin after direct application of ascorbic acid, both formulations demonstrated a equivalent antioxidant protection across all measured parameters. These results indicate that a lower concentration of Ascorbyl Glucoside can offer efficacy comparable to that of ascorbic acid, while benefiting from improved chemical stability.
Ascorbyl Glucoside is also being studied for its potential depigmenting effect. It acts by modulating tyrosinase activity, a key enzyme in melanin synthesis, which may contribute to a gradual decrease in hyperpigmentation and a more uniform skin tone. A clinical study conducted on 27 Japanese women presenting with solar lentigines evaluated the effect of an Ascorbyl Glucoside-arginine complex (AGAC) applied as a 28% lotion twice daily for 24 weeks on one side of the face, compared with a placebo on the other side. The results showed a significant reduction in pigmentation scores in the treated area compared with the placebo as early as 12 weeks, with even more pronounced effects at 24 weeks. However, the researchers did not disclose the numerical values.
This suggests that ascorbyl glucoside could be relevant for preventing and mitigating the signs of photoaging.
Note : Studies in vitro have also demonstrated that Ascorbyl Glucoside inhibits the activity of collagenase and elastase, two enzymes responsible, respectively, for the degradation of collagen and elastin. This mechanism of action, if confirmed in vivo, could also be valuable for combating signs of skin aging.